Advertisement
Screener

Myomo, Inc. (MYO) Pre-Tax Income

2.8 / 5 stars · 68/120 Roast Me

Myomo, Inc. Pre-Tax Income

Myomo, Inc. (MYO) reported Pre-Tax Income of -$3.99 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Income Statement › Pre-tax Income

us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest · last filed 2026-08-05

  • Myomo, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2026-06-30 was -$3.99M.
  • Myomo, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2026-03-31 was -$2.82M.
  • Myomo, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2025-12-31 was -$3.73M.
  • Myomo, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2025-09-30 was -$3.53M.
  • Myomo, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2025 was -$15.07M.
  • Myomo, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2024 was -$5.82M.
  • Myomo, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2023 was -$7.99M.
  • Myomo, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2022 was -$10.65M.
Period endIncome (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3 monthIncome (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6 monthIncome (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9 monthIncome (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 month
2026-06-30-$3.99M
10-Q · filed 2026-08-05
-$6.81M
10-Q · filed 2026-08-05
-$10.54M
derived: sum of 3 quarters · filed 2026-08-05
-$14.07M
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31-$2.82M
10-Q · filed 2026-05-07
-$6.55M
derived: sum of 2 quarters · filed 2026-05-07
-$10.08M
derived: sum of 3 quarters · filed 2026-05-07
-$14.56M
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31-$3.73M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09
-$7.26M
derived: sum of 2 quarters · filed 2026-03-09
-$11.74M
derived: sum of 3 quarters · filed 2026-08-05
-$15.07M
10-K · filed 2026-03-09
2025-09-30-$3.53M
10-Q · filed 2025-11-10
-$8.01M
derived: sum of 2 quarters · filed 2026-08-05
-$11.34M
10-Q · filed 2025-11-10
-$11.51M
derived: sum of 4 quarters · filed 2026-08-05
2025-06-30-$4.48M
10-Q · filed 2026-08-05
-$7.81M
10-Q · filed 2026-08-05
-$7.99M
derived: sum of 3 quarters · filed 2026-08-05
-$8.87M
derived: sum of 4 quarters · filed 2026-08-05
2025-03-31-$3.33M
10-Q · filed 2026-05-07
-$3.50M
derived: sum of 2 quarters · filed 2026-05-07
-$4.39M
derived: sum of 3 quarters · filed 2026-05-07
-$5.39M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31-$175.28K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09
-$1.06M
derived: sum of 2 quarters · filed 2026-03-09
-$2.06M
derived: sum of 3 quarters · filed 2026-03-09
-$5.82M
10-K · filed 2026-03-09
2024-09-30-$881.53K
10-Q · filed 2025-11-10
-$1.89M
derived: sum of 2 quarters · filed 2025-11-10
-$5.64M
10-Q · filed 2025-11-10
-$8.03M
derived: sum of 4 quarters · filed 2025-11-10
2024-06-30-$1.01M
10-Q · filed 2025-08-11
-$4.76M
10-Q · filed 2025-08-11
-$7.15M
derived: sum of 3 quarters · filed 2025-08-11
-$9.13M
derived: sum of 4 quarters · filed 2025-08-11
2024-03-31-$3.75M
10-Q · filed 2025-05-07
-$6.14M
derived: sum of 2 quarters · filed 2025-05-07
-$8.13M
derived: sum of 3 quarters · filed 2025-05-07
-$9.14M
derived: sum of 4 quarters · filed 2025-05-07
2023-12-31-$2.39M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10
-$4.37M
derived: sum of 2 quarters · filed 2025-03-10
-$5.39M
derived: sum of 3 quarters · filed 2025-03-10
-$7.99M
10-K · filed 2025-03-10
2023-09-30-$1.98M
10-Q · filed 2024-11-06
-$3.00M
derived: sum of 2 quarters · filed 2024-11-06
-$5.60M
10-Q · filed 2024-11-06
-$7.79M
derived: sum of 4 quarters · filed 2024-11-06
2023-06-30-$1.02M
10-Q · filed 2024-08-06
-$3.62M
10-Q · filed 2024-08-06
-$5.81M
derived: sum of 3 quarters · filed 2024-08-06
-$8.62M
derived: sum of 4 quarters · filed 2024-08-06
2023-03-31-$2.60M
10-Q · filed 2024-05-08
-$4.79M
derived: sum of 2 quarters · filed 2024-05-08
-$7.60M
derived: sum of 3 quarters · filed 2024-05-08
-$10.51M
derived: sum of 4 quarters · filed 2024-05-08
2022-12-31-$2.19M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08
-$5.00M
derived: sum of 2 quarters · filed 2024-03-08
-$7.91M
derived: sum of 3 quarters · filed 2024-03-08
-$10.65M
10-K · filed 2024-03-08
2022-09-30-$2.81M
10-Q · filed 2023-11-07
-$5.72M
derived: sum of 2 quarters · filed 2023-11-07
-$8.46M
10-Q · filed 2023-11-07
-$11.17M
derived: sum of 4 quarters · filed 2023-11-07
2022-06-30-$2.92M
10-Q · filed 2023-08-09
-$5.65M
10-Q · filed 2023-08-09
-$8.36M
derived: sum of 3 quarters · filed 2023-08-09
-$10.40M
derived: sum of 4 quarters · filed 2023-08-09
2022-03-31-$2.74M
10-Q · filed 2023-05-10
-$5.45M
derived: sum of 2 quarters · filed 2023-05-10
-$7.48M
derived: sum of 3 quarters · filed 2023-05-10
-$10.09M
derived: sum of 4 quarters · filed 2023-05-10
2021-12-31-$2.71M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13
-$4.75M
derived: sum of 2 quarters · filed 2023-03-13
-$7.35M
derived: sum of 3 quarters · filed 2023-03-13
-$10.28M
10-K · filed 2023-03-13
2021-09-30-$2.03M
10-Q · filed 2022-11-10
-$4.64M
derived: sum of 2 quarters · filed 2022-11-10
-$7.57M
10-Q · filed 2022-11-10
-$9.27M
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30-$2.61M
10-Q · filed 2022-08-03
-$5.54M
10-Q · filed 2022-08-03
-$7.24M
derived: sum of 3 quarters · filed 2022-08-03
-$10.01M
derived: sum of 4 quarters · filed 2022-08-03
2021-03-31-$2.93M
10-Q · filed 2022-05-11
-$4.63M
derived: sum of 2 quarters · filed 2022-05-11
-$7.41M
derived: sum of 3 quarters · filed 2022-05-11
-$10.70M
derived: sum of 4 quarters · filed 2022-05-11
2020-12-31-$1.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11
-$4.48M
derived: sum of 2 quarters · filed 2022-03-11
-$7.76M
derived: sum of 3 quarters · filed 2022-03-11
-$11.56M
10-K · filed 2022-03-11
2020-09-30-$2.78M
10-Q · filed 2021-11-10
-$6.06M
derived: sum of 2 quarters · filed 2021-11-10
-$9.86M
10-Q · filed 2021-11-10
2020-06-30-$3.29M
10-Q · filed 2021-08-09
-$7.09M
10-Q · filed 2021-08-09
2020-03-31-$3.80M
10-Q · filed 2021-05-05
2019-09-30-$2.79M
10-Q · filed 2020-11-10
-$5.35M
derived: sum of 2 quarters · filed 2020-11-10
-$7.95M
10-Q · filed 2020-11-10
2019-06-30-$2.57M
10-Q · filed 2020-08-10
-$5.16M
10-Q · filed 2020-08-10
2019-03-31-$2.60M
10-Q · filed 2020-05-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Envoy Medical, Inc. (COCH)United States$0.056B
ALPHA PRO TECH LTD (APT)$0.052B13.63
Safe Pro Group Inc. (SPAI)United States$0.090B
MILESTONE SCIENTIFIC INC. (MLSS)United States$0.036B-6.85
LAKELAND INDUSTRIES INC (LAKE)United States$0.104B-4.21
NutriBand Inc. (NTRB)United States$0.109B
Lifeward Ltd. (LFWD)$0.021B
Conexeu Sciences Inc. (CNXU)United States$0.111B
ENvue Medical, Inc. (FEED)United States$0.011B
Bone Biologics Corp (BBLG)United States$0.001B